Bioretec Valuation Multiples

Bioretec Overview

About Bioretec

Bioretec Ltd is a medical device company focusing on the development of safe, and reliable bioabsorbable and bioresorbable implants for pediatric and adult orthopedics. The company's products are used world wide and continue to further develop materials and products for high-load-bearing clinical applications. Some of its brands include RemeOs, Activa IM-N, ActivaPi, and ActivaScrew.

Founded

2003

HQ

Employees

47

Website

bioretec.com

Sectors

Medical DevicesHealthTechDeepTech

Financials (LTM)

Revenue: $5M

EBITDA: ($10M)

EV

$3M

Valuation Multiples

Multiples.vc

Start free trial

Bioretec Financials

Bioretec reported last 12-month revenue of $5M and negative EBITDA of ($10M).

In the same LTM period, Bioretec generated ($10M) in gross profit, ($10M) in EBITDA losses, and had net loss of ($10M).

Bioretec P&L

In the most recent fiscal year, Bioretec reported revenue of $4M and EBITDA of ($10M).

Bioretec expects next 12-month revenue of XXX and NTM EBITDA of XXX

Bioretec Stock Performance

Bioretec has current market cap of $7M, and enterprise value of $3M.

Bioretec's stock price is $0.02.

Bioretec Valuation Multiples

Bioretec trades at 0.7x EV/Revenue multiple, and (0.3x) EV/EBITDA.

Bioretec Financial Valuation Multiples

As of April 20, 2026, Bioretec has market cap of $7M and EV of $3M.

Equity research analysts estimate Bioretec's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Bioretec has a P/E ratio of (0.7x).

Bioretec Margins & Growth Rates

Bioretec's revenue in the last 12 month grew by 49%.

Bioretec's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.3M for the same period.

Bioretec's rule of 40 is (112%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Bioretec's rule of X is (52%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Bioretec Public Comps

See public comps and valuation multiples for other Medical Devices comps.

Bioretec M&A Activity

Bioretec acquired XXX companies to date.

Last acquisition by Bioretec was on XXXXXXXX, XXXXX. Bioretec acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Bioretec Investment Activity

Bioretec invested in XXX companies to date.

Bioretec made its latest investment on XXXXXXXX, XXXXX. Bioretec invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).